[go: up one dir, main page]

DK3209308T3 - Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf - Google Patents

Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf Download PDF

Info

Publication number
DK3209308T3
DK3209308T3 DK15853612.8T DK15853612T DK3209308T3 DK 3209308 T3 DK3209308 T3 DK 3209308T3 DK 15853612 T DK15853612 T DK 15853612T DK 3209308 T3 DK3209308 T3 DK 3209308T3
Authority
DK
Denmark
Prior art keywords
methods
activated bifidobacteria
bifidobacteria
activated
Prior art date
Application number
DK15853612.8T
Other languages
English (en)
Inventor
David Kyle
David Mills
Samara Freeman-Sharkey
Original Assignee
Evolve Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55761664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3209308(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evolve Biosystems Inc filed Critical Evolve Biosystems Inc
Application granted granted Critical
Publication of DK3209308T3 publication Critical patent/DK3209308T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK15853612.8T 2014-10-24 2015-10-23 Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf DK3209308T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462068553P 2014-10-24 2014-10-24
US201562133243P 2015-03-13 2015-03-13
PCT/US2015/057226 WO2016065324A1 (en) 2014-10-24 2015-10-23 Activated bifidobacteria and methods of use thereof

Publications (1)

Publication Number Publication Date
DK3209308T3 true DK3209308T3 (da) 2022-10-03

Family

ID=55761664

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15853612.8T DK3209308T3 (da) 2014-10-24 2015-10-23 Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf

Country Status (10)

Country Link
US (2) US10716816B2 (da)
EP (1) EP3209308B1 (da)
CN (2) CN114376234A (da)
AU (3) AU2015335601A1 (da)
BR (1) BR112017008284A8 (da)
CA (1) CA2965663C (da)
DK (1) DK3209308T3 (da)
MX (1) MX382478B (da)
SG (2) SG11201703298SA (da)
WO (1) WO2016065324A1 (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
BR112017008284A8 (pt) 2014-10-24 2023-04-11 Evolve Biosystems Inc Bifidobactérias ativadas e métodos para uso das mesmas
EP3212001A4 (en) 2014-10-31 2018-04-25 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
LT3193901T (lt) 2014-12-23 2018-06-11 4D Pharma Research Limited Pirino polipeptidas ir imuninė moduliacija
EP3065748B1 (en) 2014-12-23 2017-11-22 4D Pharma Research Limited A bacteroides thetaiotaomicron strain and its use in reducing inflammation
ES3004085T3 (en) * 2015-03-05 2025-03-11 Nestle Sa Compositions for use in improving stool consistency or frequency in infants or young children
AU2016233529B2 (en) * 2015-03-13 2022-03-10 Evolve Biosystems, Inc. Compositions that metabolize or sequester free sugar monomers and uses thereof
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
ES2748812T3 (es) 2015-06-15 2020-03-18 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
RS63089B1 (sr) 2015-06-15 2022-04-29 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
PT3240554T (pt) 2015-06-15 2019-11-04 4D Pharma Res Ltd Blautia stercosis e wexlerae para uso no tratamento de doenças inflamatórias e autoimunes
SI3209310T1 (en) 2015-11-20 2018-06-29 4D Pharma Research Limited Compositions containing bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
EP3520801A1 (en) 2016-03-04 2019-08-07 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
BR112018068261A2 (pt) * 2016-03-11 2019-01-15 Evolve Biosystems Inc microorganismo comensal transitório para melhorar a saúde do intestino
EP3478093A4 (en) * 2016-07-01 2020-03-04 Evolve Biosystems, Inc. Method for facilitating maturation of the mammalian immune system
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
TWI787272B (zh) 2017-05-22 2022-12-21 英商4D製藥研究有限公司 包含細菌菌株之組合物
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
ES2841902T3 (es) 2017-06-14 2021-07-12 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
WO2018229236A2 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
SG11201912105PA (en) 2017-06-14 2020-01-30 4D Pharma Res Ltd Compositions comprising bacterial strains
EP3648617A1 (en) * 2017-07-07 2020-05-13 Société des Produits Nestlé S.A. Human milk fortifier
CN107365705B (zh) * 2017-07-14 2021-01-12 江苏微康生物科技有限公司 一种油溶性益生菌冻干菌粉的冻干保护剂及其应用
EP3675882A4 (en) 2017-08-30 2021-07-28 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN111587376A (zh) * 2017-09-13 2020-08-25 进化生物系统股份有限公司 哺乳动物婴儿的代谢组学修正
WO2019143871A1 (en) 2018-01-17 2019-07-25 Evolve Biosystems, Inc. Activation of conditionally-expressed oligosaccharide pathways during fermentation of probiotic strains
US20220010267A1 (en) * 2018-05-30 2022-01-13 Evolve Biosystems, Inc. Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis
EP3801067A4 (en) * 2018-06-01 2022-03-09 Evolve Biosystems Inc. COMPOSITIONS AND METHODS FOR ENHANCEMENT OF VERTEBRAL DEFENSE AND FOR STIMULATING, EXPANDING, STRETCHING OR RESETTING T-CELL REPERTOIRES
WO2019246316A1 (en) * 2018-06-19 2019-12-26 Evolve Biosystems, Inc. Novel oligosaccharides for use in prebiotic applications
JP2021532097A (ja) 2018-07-19 2021-11-25 ペンデュラム セラピューティクス， インコーポレイテッド 微生物生着のための方法および組成物
MX2021010118A (es) 2019-02-22 2021-11-12 Aquero Canada Ltd Composiciones lacteas fortificadas y sus procesos de preparacion.
JP2023519115A (ja) * 2020-03-20 2023-05-10 グリコム・アクティーゼルスカブ 固形のｈｍｏ製品を提供するための方法及びそれにより得られる固形のｈｍｏ製品
CN111826324A (zh) * 2020-08-05 2020-10-27 厦门惠盈动物科技有限公司 一种鼠李糖乳杆菌菌粉的制备方法
WO2022036225A1 (en) * 2020-08-14 2022-02-17 Prolacta Bioscience, Inc. Human milk oligosaccharide compositions for use with bacteriotherapies
CN114568520A (zh) * 2020-11-30 2022-06-03 内蒙古伊利实业集团股份有限公司 包含长双歧杆菌婴儿亚种的婴幼儿配方粉及其应用
CN114568516A (zh) * 2020-11-30 2022-06-03 内蒙古伊利实业集团股份有限公司 包含长双歧杆菌婴儿亚种与母乳低聚糖的组合物及其应用
CN116615203B (zh) 2020-12-11 2025-03-07 帝斯曼知识产权资产管理有限公司 改进的益生元制剂
IT202100024911A1 (it) * 2021-09-29 2023-03-29 Univ Degli Studi Di Napoli Federico Ii Dipartimento Di Fisica Ettore Pancini Prebiotico a base di "scotta" delattosata per la prevenzione e gestione della disbiosi intestinale
CN116407484B (zh) * 2021-12-29 2025-08-26 嘉必优生物技术（武汉）股份有限公司 一种修护皮肤屏障的护肤组合物及其应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716615A (en) 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
RU2180915C1 (ru) 2001-04-28 2002-03-27 Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского Консорциум бифидобактерий и лактобацилл, используемый для приготовления бактериальных препаратов, заквасок для кисломолочных продуктов, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, предназначенных для коррекции микрофлоры детей в возрасте до 3-х лет
AU2004283626B2 (en) * 2003-10-24 2010-07-15 N.V. Nutricia Synbiotic composition for infants
US20070082087A1 (en) * 2005-10-06 2007-04-12 Schweitzer Biotech Company Ltd. Fermented milk products containing bifidobacterium longum and isomalto oligosaccharide and the process for producing the same
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
CA2690058A1 (en) 2006-06-09 2007-12-13 9205-5961 Quebec Inc. Fermented probiotic beverages and uses thereof
EP2069520A4 (en) * 2006-09-15 2010-05-05 Univ California GENESQUES FROM BIFIDOBACTERIA AND THEIR USE
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
UA32462U (uk) 2008-02-14 2008-05-12 Харьковский Национальный Медицинский Университет Спосіб оцінки ефективності корекції порушень мікробіоценозу кишечнику у дітей молодшого віку з атопічним дерматитом
CA2658440C (en) * 2008-04-04 2016-08-23 Kraft Foods Global Brands Llc Dairy composition with probiotics and anti-microbial system
EP2143341A1 (en) 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
EP2303294A1 (en) 2008-05-27 2011-04-06 Nestec S.A. Probiotics to improve gut microbiota
EP2352389B1 (en) * 2008-11-11 2016-01-06 Alimentary Health Limited Bifidobacterium longum
JP2012510476A (ja) 2008-12-02 2012-05-10 プロラクタ バイオサイエンス，インコーポレイテッド ヒト乳透過組成物ならびにその製造および使用方法
US9649380B2 (en) 2009-01-12 2017-05-16 Pfizer Italia S.R.L. Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
US8198872B2 (en) 2009-03-10 2012-06-12 Honeywell International, Inc. Starter-generator with improved excitation
US7888062B1 (en) * 2010-02-01 2011-02-15 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
RU2012140011A (ru) 2010-02-19 2014-03-27 Глюком А/С Получение 6'-о-сиалиллактозы и промежуточные соединения
US9200091B2 (en) 2010-07-12 2015-12-01 The Regents Of The University Of California Bovine milk oligosaccharides
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465509A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
CA2822660C (en) * 2010-12-31 2021-09-07 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides
BR112013020108A2 (pt) * 2011-02-10 2017-06-13 Nestec Sa modulação do crescimento de bifidobactérias usando uma combinação de oligossacarídeos encontrados no leite de ser humano
US9579353B2 (en) 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
EP2814835B1 (en) 2012-02-14 2019-04-10 The Regents Of The University Of California Enzymes and methods for cleaving n-glycans from glycoproteins
US10165788B2 (en) 2013-06-17 2019-01-01 The Regents Of The University Of California Methods and compositions for improved digestion of milk oligosaccharides
BR112017008284A8 (pt) 2014-10-24 2023-04-11 Evolve Biosystems Inc Bifidobactérias ativadas e métodos para uso das mesmas
ES2862176T3 (es) 2014-12-12 2021-10-07 Univ California Reducción de los glucanos de la leche y sus productos de degradación en el intestino del recién nacido

Also Published As

Publication number Publication date
CN114376234A (zh) 2022-04-22
SG10202002593SA (en) 2020-05-28
CA2965663C (en) 2023-04-04
BR112017008284A2 (pt) 2017-12-19
EP3209308B1 (en) 2022-08-03
WO2016065324A1 (en) 2016-04-28
CA2965663A1 (en) 2016-04-28
US20170304375A1 (en) 2017-10-26
BR112017008284A8 (pt) 2023-04-11
EP3209308A4 (en) 2018-06-27
AU2021204822A1 (en) 2021-08-05
US20200397837A1 (en) 2020-12-24
MX382478B (es) 2025-03-13
CN107249611A (zh) 2017-10-13
US10716816B2 (en) 2020-07-21
SG11201703298SA (en) 2017-05-30
NZ731722A (en) 2024-11-29
EP3209308A1 (en) 2017-08-30
AU2024264651A1 (en) 2025-03-13
AU2015335601A1 (en) 2017-06-01
MX2017005260A (es) 2018-01-30

Similar Documents

Publication Publication Date Title
DK3209308T3 (da) Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf
DK3215532T3 (da) Anti-TIM3-antistoffer og fremgangsmåder til anvendelse
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3201351T3 (da) Kaloriefrie sødestoffer og fremgangsmåder til syntetisering
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3353210T3 (da) Anti-TIGIT-antistoffer og fremgangsmåder til anvendelse
DK3828194T3 (da) Oxysteroler og fremgangsmåder til anvendelse deraf
DK3394065T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf
DK3210977T3 (da) Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3212189T3 (da) Substituerede chromaner og fremgangsmåde til anvendelse deraf
DK3227336T3 (da) Anti-CD79b-antistoffer og fremgangsmåder til anvendelse
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3172213T3 (da) Makrocykliske kinasehæmmere og anvendelser deraf
DK3230319T3 (da) Anti-PD-1-antistoffer og fremgangsmåder til anvendelse deraf
DK3725357T3 (da) Opholdsstrukturer og relaterede fremgangsmåder
DK3148579T3 (da) Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf
DK3521289T3 (da) Mnk-inhibitorer og fremgangsmåder forbundet dermed
DK3229838T3 (da) Anti-C10orf54-antistoffer og anvendelser deraf
DK3089971T3 (da) Forbindelser og fremgangsmåder til anvendelse
DK3126388T3 (da) Anti-EGFRvIII-antistoffer og anvendelser deraf
DK3220973T3 (da) Kunstigt lungesystem og fremgangsmåder til anvendelse deraf
DK3015526T3 (da) Hydrofluorolefinbaseret sammensætning og anvendelse deraf
DK3812392T3 (da) Oxysteroler og fremgangsmåder til anvendelse deraf
DK3511019T3 (da) Terapeutiske nanopartikler omfattende et terapeutisk middel og fremgangsmåder til fremstilling og anvendelse deraf